University of Modena and Reggio Emilia at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Modena and Reggio Emilia brings 8 presentations to ESGCT 2026 in Hamburg. Its work centres on gene editing for inherited skin and corneal diseases, including epidermolysis bullosa. Other strands deliver editors in lipid nanoparticles to the retina, test in vivo base editing for Krabbe disease and aim CAR T cells at Ewing sarcoma.
| Organization | ESGCT 2026 Attendance |
|---|---|
University of Modena and Reggio Emilia Modena, Italy | |
Italian university whose regenerative medicine centre develops epithelial stem cell gene therapies for skin and eye diseases. | Poster Wed Oct 28 1:30pm–3:30pm Anti-GD2 CAR T cells efficiently target Ewing’s sarcoma Poster Wed Oct 28 1:30pm–3:30pm Lipid Nanoparticle-Mediated mRNA Delivery of CRISPR Editors in Retinal Cell Cultures Talk Thu Oct 29 9:45am–10:30am Allele-specific CRISPR/Cas9 editing of TP63 paves the way toward precision therapy for EEC-related corneal disease Gene and epigenome editingRare and inherited disease Poster Thu Oct 29 2:00pm–4:00pm Brain-targeted in vivo base editing for correction of Krabbe disease Poster Thu Oct 29 2:00pm–4:00pm CRISPR-based functional genomics for rAAV production Poster Thu Oct 29 2:00pm–4:00pm RPE-targeted delivery of LNPs loaded with saRNA as a therapeutic approach for retinal degeneration Poster Thu Oct 29 2:00pm–4:00pm Universal gene editing for epidermolysis bullosa simplex via large template-driven homology-directed repair Talk Fri Oct 30 11:30am–1:00pm In Vivo Base Editing for the Treatment of Multisystemic Disorders. Gene and epigenome editingRare and inherited disease |
Instantly find 20 buyers from University of Modena and Reggio Emilia
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction